nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—CALY—malignant glioma	0.759	1	CbGaD
Trifluoperazine—HTR2C—choroid plexus—malignant glioma	0.00761	0.0908	CbGeAlD
Trifluoperazine—Edema cerebral—Carmustine—malignant glioma	0.00632	0.117	CcSEcCtD
Trifluoperazine—Edema cerebral—Temozolomide—malignant glioma	0.00611	0.113	CcSEcCtD
Trifluoperazine—HTR2A—choroid plexus—malignant glioma	0.00382	0.0456	CbGeAlD
Trifluoperazine—Brain oedema—Carmustine—malignant glioma	0.00342	0.0633	CcSEcCtD
Trifluoperazine—Brain oedema—Temozolomide—malignant glioma	0.00331	0.0612	CcSEcCtD
Trifluoperazine—Pigmentation disorder—Temozolomide—malignant glioma	0.00283	0.0524	CcSEcCtD
Trifluoperazine—CALM2—pons—malignant glioma	0.00224	0.0268	CbGeAlD
Trifluoperazine—CALM1—pons—malignant glioma	0.00223	0.0266	CbGeAlD
Trifluoperazine—HTR2C—telencephalic ventricle—malignant glioma	0.00223	0.0266	CbGeAlD
Trifluoperazine—HTR2A—cerebellar cortex—malignant glioma	0.00192	0.0229	CbGeAlD
Trifluoperazine—S100A4—embryo—malignant glioma	0.00189	0.0226	CbGeAlD
Trifluoperazine—HTR1A—telencephalic ventricle—malignant glioma	0.00188	0.0224	CbGeAlD
Trifluoperazine—CALY—telencephalon—malignant glioma	0.00178	0.0213	CbGeAlD
Trifluoperazine—DRD2—telencephalic ventricle—malignant glioma	0.0017	0.0202	CbGeAlD
Trifluoperazine—CALM2—pineal body—malignant glioma	0.0016	0.0191	CbGeAlD
Trifluoperazine—CALM1—pineal body—malignant glioma	0.00159	0.019	CbGeAlD
Trifluoperazine—CALY—medulla oblongata—malignant glioma	0.0014	0.0167	CbGeAlD
Trifluoperazine—HTR2A—pons—malignant glioma	0.00136	0.0162	CbGeAlD
Trifluoperazine—HTR2A—vertebral column—malignant glioma	0.00135	0.0161	CbGeAlD
Trifluoperazine—CALY—midbrain—malignant glioma	0.00128	0.0153	CbGeAlD
Trifluoperazine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00125	0.0232	CcSEcCtD
Trifluoperazine—CALY—spinal cord—malignant glioma	0.00125	0.0149	CbGeAlD
Trifluoperazine—Cholestasis—Temozolomide—malignant glioma	0.00124	0.023	CcSEcCtD
Trifluoperazine—S100A4—medulla oblongata—malignant glioma	0.00121	0.0144	CbGeAlD
Trifluoperazine—Liver injury—Temozolomide—malignant glioma	0.00112	0.0208	CcSEcCtD
Trifluoperazine—HTR2A—telencephalic ventricle—malignant glioma	0.00112	0.0133	CbGeAlD
Trifluoperazine—EBPL—central nervous system—malignant glioma	0.00111	0.0132	CbGeAlD
Trifluoperazine—S100A4—midbrain—malignant glioma	0.0011	0.0132	CbGeAlD
Trifluoperazine—EBPL—cerebellum—malignant glioma	0.00108	0.0129	CbGeAlD
Trifluoperazine—S100A4—spinal cord—malignant glioma	0.00108	0.0129	CbGeAlD
Trifluoperazine—Amenorrhoea—Temozolomide—malignant glioma	0.00108	0.0199	CcSEcCtD
Trifluoperazine—CALY—central nervous system—malignant glioma	0.00101	0.0121	CbGeAlD
Trifluoperazine—Gait disturbance—Carmustine—malignant glioma	0.001	0.0185	CcSEcCtD
Trifluoperazine—CALY—cerebellum—malignant glioma	0.00099	0.0118	CbGeAlD
Trifluoperazine—CALM2—endothelium—malignant glioma	0.00099	0.0118	CbGeAlD
Trifluoperazine—CALM1—endothelium—malignant glioma	0.000985	0.0118	CbGeAlD
Trifluoperazine—HTR2A—pineal body—malignant glioma	0.00097	0.0116	CbGeAlD
Trifluoperazine—Gait disturbance—Temozolomide—malignant glioma	0.000968	0.0179	CcSEcCtD
Trifluoperazine—HTR6—telencephalon—malignant glioma	0.000926	0.0111	CbGeAlD
Trifluoperazine—CALM2—blood vessel—malignant glioma	0.000913	0.0109	CbGeAlD
Trifluoperazine—CALM1—blood vessel—malignant glioma	0.000908	0.0108	CbGeAlD
Trifluoperazine—Aplastic anaemia—Temozolomide—malignant glioma	0.000887	0.0164	CcSEcCtD
Trifluoperazine—EBPL—brain—malignant glioma	0.000879	0.0105	CbGeAlD
Trifluoperazine—Gynaecomastia—Carmustine—malignant glioma	0.000875	0.0162	CcSEcCtD
Trifluoperazine—S100A4—cerebellum—malignant glioma	0.000855	0.0102	CbGeAlD
Trifluoperazine—CALY—brain—malignant glioma	0.000804	0.0096	CbGeAlD
Trifluoperazine—Nasal congestion—Temozolomide—malignant glioma	0.000753	0.0139	CcSEcCtD
Trifluoperazine—Clozapine—CALY—malignant glioma	0.00074	0.226	CrCbGaD
Trifluoperazine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000727	0.0134	CcSEcCtD
Trifluoperazine—S100A4—brain—malignant glioma	0.000694	0.00829	CbGeAlD
Trifluoperazine—Muscular weakness—Carmustine—malignant glioma	0.000626	0.0116	CcSEcCtD
Trifluoperazine—Dysphagia—Carmustine—malignant glioma	0.000613	0.0113	CcSEcCtD
Trifluoperazine—CALM3—retina—malignant glioma	0.000613	0.00732	CbGeAlD
Trifluoperazine—Muscular weakness—Temozolomide—malignant glioma	0.000605	0.0112	CcSEcCtD
Trifluoperazine—HTR2C—brainstem—malignant glioma	0.000603	0.0072	CbGeAlD
Trifluoperazine—HTR2A—endothelium—malignant glioma	0.0006	0.00716	CbGeAlD
Trifluoperazine—Dysphagia—Temozolomide—malignant glioma	0.000593	0.011	CcSEcCtD
Trifluoperazine—Pancytopenia—Carmustine—malignant glioma	0.000583	0.0108	CcSEcCtD
Trifluoperazine—Antrafenine—PTGS1—malignant glioma	0.000574	0.175	CrCbGaD
Trifluoperazine—CALM3—telencephalon—malignant glioma	0.000564	0.00673	CbGeAlD
Trifluoperazine—Pancytopenia—Temozolomide—malignant glioma	0.000563	0.0104	CcSEcCtD
Trifluoperazine—CHRM2—telencephalon—malignant glioma	0.000555	0.00663	CbGeAlD
Trifluoperazine—HTR2A—blood vessel—malignant glioma	0.000553	0.00661	CbGeAlD
Trifluoperazine—Hyperglycaemia—Carmustine—malignant glioma	0.000553	0.0102	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Temozolomide—malignant glioma	0.000546	0.0101	CcSEcCtD
Trifluoperazine—CALM2—embryo—malignant glioma	0.000544	0.0065	CbGeAlD
Trifluoperazine—CALM1—embryo—malignant glioma	0.000542	0.00647	CbGeAlD
Trifluoperazine—Photosensitivity reaction—Temozolomide—malignant glioma	0.000541	0.01	CcSEcCtD
Trifluoperazine—Weight increased—Temozolomide—malignant glioma	0.00054	0.00998	CcSEcCtD
Trifluoperazine—HTR2C—telencephalon—malignant glioma	0.000535	0.00639	CbGeAlD
Trifluoperazine—Hyperglycaemia—Temozolomide—malignant glioma	0.000535	0.00989	CcSEcCtD
Trifluoperazine—HTR6—central nervous system—malignant glioma	0.000526	0.00629	CbGeAlD
Trifluoperazine—HTR1A—brainstem—malignant glioma	0.000508	0.00606	CbGeAlD
Trifluoperazine—SIGMAR1—telencephalon—malignant glioma	0.000504	0.00602	CbGeAlD
Trifluoperazine—CALM2—brainstem—malignant glioma	0.000499	0.00596	CbGeAlD
Trifluoperazine—CALM1—brainstem—malignant glioma	0.000497	0.00593	CbGeAlD
Trifluoperazine—Oedema peripheral—Carmustine—malignant glioma	0.000484	0.00895	CcSEcCtD
Trifluoperazine—CALM2—retina—malignant glioma	0.000481	0.00575	CbGeAlD
Trifluoperazine—CALM1—retina—malignant glioma	0.000479	0.00572	CbGeAlD
Trifluoperazine—ADRA1A—brainstem—malignant glioma	0.000468	0.00559	CbGeAlD
Trifluoperazine—Oedema peripheral—Temozolomide—malignant glioma	0.000467	0.00865	CcSEcCtD
Trifluoperazine—DRD2—brainstem—malignant glioma	0.000459	0.00548	CbGeAlD
Trifluoperazine—HTR1A—telencephalon—malignant glioma	0.000451	0.00538	CbGeAlD
Trifluoperazine—CALM3—medulla oblongata—malignant glioma	0.000443	0.00529	CbGeAlD
Trifluoperazine—CALM2—telencephalon—malignant glioma	0.000443	0.00529	CbGeAlD
Trifluoperazine—DRD2—retina—malignant glioma	0.000443	0.00528	CbGeAlD
Trifluoperazine—CALM1—telencephalon—malignant glioma	0.000441	0.00526	CbGeAlD
Trifluoperazine—Erythema—Carmustine—malignant glioma	0.000427	0.00791	CcSEcCtD
Trifluoperazine—HTR2C—medulla oblongata—malignant glioma	0.000421	0.00502	CbGeAlD
Trifluoperazine—HTR6—brain—malignant glioma	0.000418	0.00499	CbGeAlD
Trifluoperazine—ADRA1A—telencephalon—malignant glioma	0.000415	0.00496	CbGeAlD
Trifluoperazine—Erythema—Temozolomide—malignant glioma	0.000413	0.00764	CcSEcCtD
Trifluoperazine—DRD2—telencephalon—malignant glioma	0.000407	0.00486	CbGeAlD
Trifluoperazine—CALM3—midbrain—malignant glioma	0.000405	0.00483	CbGeAlD
Trifluoperazine—Vision blurred—Carmustine—malignant glioma	0.000403	0.00745	CcSEcCtD
Trifluoperazine—Tremor—Carmustine—malignant glioma	0.0004	0.00741	CcSEcCtD
Trifluoperazine—SIGMAR1—medulla oblongata—malignant glioma	0.000396	0.00473	CbGeAlD
Trifluoperazine—CALM3—spinal cord—malignant glioma	0.000395	0.00472	CbGeAlD
Trifluoperazine—Agitation—Carmustine—malignant glioma	0.000393	0.00727	CcSEcCtD
Trifluoperazine—Vision blurred—Temozolomide—malignant glioma	0.000389	0.0072	CcSEcCtD
Trifluoperazine—Tremor—Temozolomide—malignant glioma	0.000387	0.00716	CcSEcCtD
Trifluoperazine—HTR2C—midbrain—malignant glioma	0.000384	0.00459	CbGeAlD
Trifluoperazine—Leukopenia—Carmustine—malignant glioma	0.000383	0.00708	CcSEcCtD
Trifluoperazine—Agitation—Temozolomide—malignant glioma	0.00038	0.00702	CcSEcCtD
Trifluoperazine—Angioedema—Temozolomide—malignant glioma	0.000377	0.00698	CcSEcCtD
Trifluoperazine—HTR2C—spinal cord—malignant glioma	0.000375	0.00448	CbGeAlD
Trifluoperazine—Convulsion—Carmustine—malignant glioma	0.00037	0.00685	CcSEcCtD
Trifluoperazine—Leukopenia—Temozolomide—malignant glioma	0.00037	0.00684	CcSEcCtD
Trifluoperazine—ABCB1—blood vessel—malignant glioma	0.000363	0.00433	CbGeAlD
Trifluoperazine—SIGMAR1—midbrain—malignant glioma	0.000362	0.00432	CbGeAlD
Trifluoperazine—Cough—Temozolomide—malignant glioma	0.00036	0.00667	CcSEcCtD
Trifluoperazine—Convulsion—Temozolomide—malignant glioma	0.000358	0.00662	CcSEcCtD
Trifluoperazine—SIGMAR1—spinal cord—malignant glioma	0.000353	0.00422	CbGeAlD
Trifluoperazine—CALM2—medulla oblongata—malignant glioma	0.000348	0.00415	CbGeAlD
Trifluoperazine—CALM1—medulla oblongata—malignant glioma	0.000346	0.00413	CbGeAlD
Trifluoperazine—Dry mouth—Temozolomide—malignant glioma	0.000344	0.00636	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Temozolomide—malignant glioma	0.000337	0.00624	CcSEcCtD
Trifluoperazine—Anorexia—Carmustine—malignant glioma	0.000333	0.00615	CcSEcCtD
Trifluoperazine—HTR2A—embryo—malignant glioma	0.00033	0.00394	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—malignant glioma	0.000328	0.1	CrCbGaD
Trifluoperazine—Skin disorder—Temozolomide—malignant glioma	0.000327	0.00606	CcSEcCtD
Trifluoperazine—Hypotension—Carmustine—malignant glioma	0.000326	0.00603	CcSEcCtD
Trifluoperazine—HTR1A—midbrain—malignant glioma	0.000324	0.00386	CbGeAlD
Trifluoperazine—HRH1—telencephalon—malignant glioma	0.000321	0.00384	CbGeAlD
Trifluoperazine—Anorexia—Temozolomide—malignant glioma	0.000321	0.00594	CcSEcCtD
Trifluoperazine—CALM2—midbrain—malignant glioma	0.000318	0.0038	CbGeAlD
Trifluoperazine—CALM1—midbrain—malignant glioma	0.000317	0.00378	CbGeAlD
Trifluoperazine—HTR1A—spinal cord—malignant glioma	0.000316	0.00377	CbGeAlD
Trifluoperazine—CHRM2—central nervous system—malignant glioma	0.000316	0.00377	CbGeAlD
Trifluoperazine—Insomnia—Carmustine—malignant glioma	0.000316	0.00584	CcSEcCtD
Trifluoperazine—CALM3—cerebellum—malignant glioma	0.000313	0.00374	CbGeAlD
Trifluoperazine—Dyspnoea—Carmustine—malignant glioma	0.000311	0.00575	CcSEcCtD
Trifluoperazine—CALM2—spinal cord—malignant glioma	0.00031	0.0037	CbGeAlD
Trifluoperazine—Somnolence—Carmustine—malignant glioma	0.00031	0.00574	CcSEcCtD
Trifluoperazine—CALM1—spinal cord—malignant glioma	0.000309	0.00369	CbGeAlD
Trifluoperazine—Insomnia—Temozolomide—malignant glioma	0.000305	0.00564	CcSEcCtD
Trifluoperazine—HTR2C—central nervous system—malignant glioma	0.000304	0.00363	CbGeAlD
Trifluoperazine—Decreased appetite—Carmustine—malignant glioma	0.000303	0.00561	CcSEcCtD
Trifluoperazine—HTR2A—brainstem—malignant glioma	0.000303	0.00361	CbGeAlD
Trifluoperazine—Dyspnoea—Temozolomide—malignant glioma	0.000301	0.00556	CcSEcCtD
Trifluoperazine—Somnolence—Temozolomide—malignant glioma	0.0003	0.00554	CcSEcCtD
Trifluoperazine—Constipation—Carmustine—malignant glioma	0.000298	0.00552	CcSEcCtD
Trifluoperazine—CYP1A2—Carmustine—malignant glioma	0.000295	1	CbGbCtD
Trifluoperazine—Decreased appetite—Temozolomide—malignant glioma	0.000293	0.00542	CcSEcCtD
Trifluoperazine—DRD2—midbrain—malignant glioma	0.000292	0.00349	CbGeAlD
Trifluoperazine—HTR2A—retina—malignant glioma	0.000292	0.00348	CbGeAlD
Trifluoperazine—Fatigue—Temozolomide—malignant glioma	0.000291	0.00538	CcSEcCtD
Trifluoperazine—Constipation—Temozolomide—malignant glioma	0.000288	0.00533	CcSEcCtD
Trifluoperazine—SIGMAR1—cerebellum—malignant glioma	0.00028	0.00334	CbGeAlD
Trifluoperazine—Body temperature increased—Carmustine—malignant glioma	0.000276	0.0051	CcSEcCtD
Trifluoperazine—HTR2A—telencephalon—malignant glioma	0.000268	0.00321	CbGeAlD
Trifluoperazine—Urticaria—Temozolomide—malignant glioma	0.000268	0.00495	CcSEcCtD
Trifluoperazine—Body temperature increased—Temozolomide—malignant glioma	0.000267	0.00493	CcSEcCtD
Trifluoperazine—Hypersensitivity—Carmustine—malignant glioma	0.000257	0.00475	CcSEcCtD
Trifluoperazine—HTR1A—central nervous system—malignant glioma	0.000256	0.00306	CbGeAlD
Trifluoperazine—CALM3—brain—malignant glioma	0.000254	0.00304	CbGeAlD
Trifluoperazine—CALM2—central nervous system—malignant glioma	0.000252	0.003	CbGeAlD
Trifluoperazine—Ethopropazine—BCHE—malignant glioma	0.000251	0.0766	CrCbGaD
Trifluoperazine—CHRM2—brain—malignant glioma	0.000251	0.00299	CbGeAlD
Trifluoperazine—CALM1—central nervous system—malignant glioma	0.000251	0.00299	CbGeAlD
Trifluoperazine—Asthenia—Carmustine—malignant glioma	0.00025	0.00463	CcSEcCtD
Trifluoperazine—HTR1A—cerebellum—malignant glioma	0.00025	0.00299	CbGeAlD
Trifluoperazine—Hypersensitivity—Temozolomide—malignant glioma	0.000248	0.00459	CcSEcCtD
Trifluoperazine—CALM2—cerebellum—malignant glioma	0.000246	0.00294	CbGeAlD
Trifluoperazine—CALM1—cerebellum—malignant glioma	0.000245	0.00292	CbGeAlD
Trifluoperazine—Asthenia—Temozolomide—malignant glioma	0.000242	0.00447	CcSEcCtD
Trifluoperazine—HTR2C—brain—malignant glioma	0.000242	0.00288	CbGeAlD
Trifluoperazine—Pruritus—Temozolomide—malignant glioma	0.000239	0.00441	CcSEcCtD
Trifluoperazine—ADRA1A—central nervous system—malignant glioma	0.000236	0.00282	CbGeAlD
Trifluoperazine—DRD2—central nervous system—malignant glioma	0.000231	0.00276	CbGeAlD
Trifluoperazine—ADRA1A—cerebellum—malignant glioma	0.000231	0.00275	CbGeAlD
Trifluoperazine—Dizziness—Carmustine—malignant glioma	0.000231	0.00427	CcSEcCtD
Trifluoperazine—SIGMAR1—brain—malignant glioma	0.000227	0.00271	CbGeAlD
Trifluoperazine—DRD2—cerebellum—malignant glioma	0.000226	0.0027	CbGeAlD
Trifluoperazine—Dizziness—Temozolomide—malignant glioma	0.000223	0.00412	CcSEcCtD
Trifluoperazine—Nefazodone—SLC6A3—malignant glioma	0.00022	0.0672	CrCbGaD
Trifluoperazine—Rash—Carmustine—malignant glioma	0.00022	0.00407	CcSEcCtD
Trifluoperazine—Dermatitis—Carmustine—malignant glioma	0.00022	0.00406	CcSEcCtD
Trifluoperazine—Headache—Carmustine—malignant glioma	0.000219	0.00404	CcSEcCtD
Trifluoperazine—ABCB1—embryo—malignant glioma	0.000216	0.00258	CbGeAlD
Trifluoperazine—Rash—Temozolomide—malignant glioma	0.000213	0.00393	CcSEcCtD
Trifluoperazine—Dermatitis—Temozolomide—malignant glioma	0.000212	0.00393	CcSEcCtD
Trifluoperazine—Headache—Temozolomide—malignant glioma	0.000211	0.00391	CcSEcCtD
Trifluoperazine—HTR2A—medulla oblongata—malignant glioma	0.000211	0.00252	CbGeAlD
Trifluoperazine—Clomipramine—GSTP1—malignant glioma	0.00021	0.0643	CrCbGaD
Trifluoperazine—Nausea—Carmustine—malignant glioma	0.000207	0.00383	CcSEcCtD
Trifluoperazine—Perphenazine—CYP2C18—malignant glioma	0.000206	0.0629	CrCbGaD
Trifluoperazine—Triflupromazine—BCHE—malignant glioma	0.000205	0.0627	CrCbGaD
Trifluoperazine—HTR1A—brain—malignant glioma	0.000203	0.00243	CbGeAlD
Trifluoperazine—Nausea—Temozolomide—malignant glioma	0.0002	0.0037	CcSEcCtD
Trifluoperazine—CALM2—brain—malignant glioma	0.0002	0.00239	CbGeAlD
Trifluoperazine—CALM1—brain—malignant glioma	0.000199	0.00237	CbGeAlD
Trifluoperazine—HTR2A—midbrain—malignant glioma	0.000193	0.0023	CbGeAlD
Trifluoperazine—ABCB1—retina—malignant glioma	0.000191	0.00228	CbGeAlD
Trifluoperazine—HTR2A—spinal cord—malignant glioma	0.000188	0.00225	CbGeAlD
Trifluoperazine—ADRA1A—brain—malignant glioma	0.000187	0.00224	CbGeAlD
Trifluoperazine—DRD2—brain—malignant glioma	0.000184	0.00219	CbGeAlD
Trifluoperazine—HRH1—central nervous system—malignant glioma	0.000183	0.00218	CbGeAlD
Trifluoperazine—ABCB1—telencephalon—malignant glioma	0.000176	0.0021	CbGeAlD
Trifluoperazine—Promethazine—CYP2B6—malignant glioma	0.000157	0.0479	CrCbGaD
Trifluoperazine—Perphenazine—CYP2B6—malignant glioma	0.000153	0.0467	CrCbGaD
Trifluoperazine—HTR2A—central nervous system—malignant glioma	0.000153	0.00182	CbGeAlD
Trifluoperazine—HTR2A—cerebellum—malignant glioma	0.000149	0.00178	CbGeAlD
Trifluoperazine—HRH1—brain—malignant glioma	0.000145	0.00173	CbGeAlD
Trifluoperazine—ABCB1—medulla oblongata—malignant glioma	0.000138	0.00165	CbGeAlD
Trifluoperazine—Loxapine—SLC6A3—malignant glioma	0.000131	0.04	CrCbGaD
Trifluoperazine—ABCB1—midbrain—malignant glioma	0.000126	0.00151	CbGeAlD
Trifluoperazine—ABCB1—spinal cord—malignant glioma	0.000123	0.00147	CbGeAlD
Trifluoperazine—HTR2A—brain—malignant glioma	0.000121	0.00145	CbGeAlD
Trifluoperazine—ABCB1—central nervous system—malignant glioma	0.0001	0.00119	CbGeAlD
Trifluoperazine—Chlorpromazine—BCHE—malignant glioma	9.9e-05	0.0303	CrCbGaD
Trifluoperazine—ABCB1—cerebellum—malignant glioma	9.77e-05	0.00117	CbGeAlD
Trifluoperazine—ABCB1—brain—malignant glioma	7.94e-05	0.000948	CbGeAlD
Trifluoperazine—HTR1A—Signaling Pathways—MMP9—malignant glioma	3.03e-06	3.03e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—RAF1—malignant glioma	3.03e-06	3.03e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	3.02e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MMP9—malignant glioma	3.01e-06	3.02e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PTEN—malignant glioma	3.01e-06	3.01e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	3.01e-06	3.01e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	3e-06	3.01e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PTEN—malignant glioma	2.99e-06	3e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	2.99e-06	3e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PIK3CB—malignant glioma	2.99e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—STAT3—malignant glioma	2.99e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	2.99e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT2—malignant glioma	2.98e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PTEN—malignant glioma	2.98e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PTEN—malignant glioma	2.98e-06	2.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—EGFR—malignant glioma	2.97e-06	2.97e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—BRAF—malignant glioma	2.96e-06	2.97e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—BRAF—malignant glioma	2.96e-06	2.97e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—malignant glioma	2.96e-06	2.96e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CG—malignant glioma	2.95e-06	2.96e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	2.95e-06	2.96e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	2.95e-06	2.95e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CXCL8—malignant glioma	2.94e-06	2.94e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	2.94e-06	2.94e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	2.92e-06	2.92e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	2.89e-06	2.89e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3CB—malignant glioma	2.89e-06	2.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3CB—malignant glioma	2.89e-06	2.89e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—STAT3—malignant glioma	2.89e-06	2.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—STAT3—malignant glioma	2.89e-06	2.89e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CXCL8—malignant glioma	2.89e-06	2.89e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT2—malignant glioma	2.88e-06	2.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT2—malignant glioma	2.88e-06	2.89e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—EGFR—malignant glioma	2.87e-06	2.88e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—EGFR—malignant glioma	2.87e-06	2.88e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—PIK3CA—malignant glioma	2.87e-06	2.87e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CD—malignant glioma	2.87e-06	2.87e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—malignant glioma	2.86e-06	2.87e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—malignant glioma	2.86e-06	2.87e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PPARG—malignant glioma	2.85e-06	2.85e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	2.84e-06	2.84e-05	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	2.84e-06	2.84e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	2.83e-06	2.83e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CASP3—malignant glioma	2.81e-06	2.82e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL2—malignant glioma	2.81e-06	2.81e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—KRAS—malignant glioma	2.81e-06	2.81e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	2.79e-06	2.8e-05	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	2.79e-06	2.79e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—malignant glioma	2.77e-06	2.78e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CD—malignant glioma	2.77e-06	2.78e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CD—malignant glioma	2.77e-06	2.78e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2.77e-06	2.77e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL2—malignant glioma	2.76e-06	2.77e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CASP3—malignant glioma	2.76e-06	2.76e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL2—malignant glioma	2.76e-06	2.76e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—STAT3—malignant glioma	2.76e-06	2.76e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—FGF2—malignant glioma	2.74e-06	2.75e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	2.74e-06	2.75e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	2.73e-06	2.74e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	2.72e-06	2.72e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CASP3—malignant glioma	2.72e-06	2.72e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—KRAS—malignant glioma	2.71e-06	2.72e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—KRAS—malignant glioma	2.71e-06	2.72e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—EGFR—malignant glioma	2.71e-06	2.72e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL2—malignant glioma	2.71e-06	2.72e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	2.71e-06	2.71e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL2—malignant glioma	2.71e-06	2.71e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	2.7e-06	2.71e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—STAT3—malignant glioma	2.69e-06	2.69e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—STAT3—malignant glioma	2.68e-06	2.68e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—STAT3—malignant glioma	2.67e-06	2.67e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—STAT3—malignant glioma	2.67e-06	2.67e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MMP9—malignant glioma	2.66e-06	2.66e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—FGF2—malignant glioma	2.65e-06	2.66e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—FGF2—malignant glioma	2.65e-06	2.66e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PTEN—malignant glioma	2.64e-06	2.65e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—EGFR—malignant glioma	2.62e-06	2.63e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EGFR—malignant glioma	2.62e-06	2.63e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—malignant glioma	2.62e-06	2.62e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—malignant glioma	2.61e-06	2.61e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PTEN—malignant glioma	2.6e-06	2.6e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CD—malignant glioma	2.6e-06	2.6e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PTEN—malignant glioma	2.59e-06	2.6e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CAV1—malignant glioma	2.59e-06	2.59e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTEN—malignant glioma	2.58e-06	2.58e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—AKT1—malignant glioma	2.58e-06	2.58e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—PIK3CA—malignant glioma	2.58e-06	2.58e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—malignant glioma	2.57e-06	2.57e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MDM2—malignant glioma	2.57e-06	2.57e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—KRAS—malignant glioma	2.56e-06	2.57e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MYC—malignant glioma	2.56e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	2.56e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—RAF1—malignant glioma	2.56e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PTEN—malignant glioma	2.55e-06	2.56e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	2.55e-06	2.55e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	2.54e-06	2.54e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—malignant glioma	2.53e-06	2.53e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ERBB2—malignant glioma	2.53e-06	2.53e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EGFR—malignant glioma	2.51e-06	2.51e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MYC—malignant glioma	2.5e-06	2.5e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CB—malignant glioma	2.5e-06	2.5e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTEN—malignant glioma	2.5e-06	2.5e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTEN—malignant glioma	2.5e-06	2.5e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PIK3CA—malignant glioma	2.49e-06	2.5e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PIK3CA—malignant glioma	2.49e-06	2.5e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	2.49e-06	2.49e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MYC—malignant glioma	2.49e-06	2.49e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	2.48e-06	2.49e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MDM2—malignant glioma	2.48e-06	2.49e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MDM2—malignant glioma	2.48e-06	2.49e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—KRAS—malignant glioma	2.48e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—KRAS—malignant glioma	2.48e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MYC—malignant glioma	2.48e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MYC—malignant glioma	2.48e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—RAF1—malignant glioma	2.47e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—RAF1—malignant glioma	2.47e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.47e-06	2.48e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ERBB2—malignant glioma	2.45e-06	2.45e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ERBB2—malignant glioma	2.45e-06	2.45e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EGFR—malignant glioma	2.45e-06	2.45e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EGFR—malignant glioma	2.43e-06	2.44e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EGFR—malignant glioma	2.42e-06	2.43e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EGFR—malignant glioma	2.42e-06	2.43e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CB—malignant glioma	2.42e-06	2.42e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CB—malignant glioma	2.42e-06	2.42e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CXCL8—malignant glioma	2.4e-06	2.4e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—malignant glioma	2.39e-06	2.39e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—KRAS—malignant glioma	2.37e-06	2.37e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—STAT3—malignant glioma	2.36e-06	2.37e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.36e-06	2.36e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—PIK3CA—malignant glioma	2.35e-06	2.36e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	2.35e-06	2.35e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—malignant glioma	2.34e-06	2.35e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—malignant glioma	2.34e-06	2.35e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—STAT3—malignant glioma	2.33e-06	2.33e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CXCL8—malignant glioma	2.32e-06	2.32e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CXCL8—malignant glioma	2.32e-06	2.32e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—STAT3—malignant glioma	2.32e-06	2.32e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—KRAS—malignant glioma	2.31e-06	2.31e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	2.31e-06	2.31e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	2.3e-06	2.3e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—KRAS—malignant glioma	2.3e-06	2.3e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—malignant glioma	2.3e-06	2.3e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL2—malignant glioma	2.29e-06	2.3e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—KRAS—malignant glioma	2.29e-06	2.29e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—KRAS—malignant glioma	2.29e-06	2.29e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—STAT3—malignant glioma	2.28e-06	2.29e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—PIK3CA—malignant glioma	2.28e-06	2.28e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—PIK3CA—malignant glioma	2.28e-06	2.28e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	2.28e-06	2.28e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARG—malignant glioma	2.28e-06	2.28e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CB—malignant glioma	2.26e-06	2.27e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—malignant glioma	2.24e-06	2.25e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—malignant glioma	2.22e-06	2.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—malignant glioma	2.22e-06	2.22e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL2—malignant glioma	2.22e-06	2.22e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL2—malignant glioma	2.22e-06	2.22e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MYC—malignant glioma	2.2e-06	2.2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PIK3CA—malignant glioma	2.17e-06	2.18e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—malignant glioma	2.17e-06	2.17e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MYC—malignant glioma	2.16e-06	2.16e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PTEN—malignant glioma	2.16e-06	2.16e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MYC—malignant glioma	2.16e-06	2.16e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EGFR—malignant glioma	2.15e-06	2.15e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	2.12e-06	2.13e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MYC—malignant glioma	2.12e-06	2.12e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MYC—malignant glioma	2.12e-06	2.12e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EGFR—malignant glioma	2.11e-06	2.12e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	2.11e-06	2.11e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EGFR—malignant glioma	2.11e-06	2.11e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—malignant glioma	2.11e-06	2.11e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PIK3CA—malignant glioma	2.1e-06	2.11e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PIK3CA—malignant glioma	2.1e-06	2.11e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—malignant glioma	2.1e-06	2.1e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—malignant glioma	2.1e-06	2.1e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PTEN—malignant glioma	2.09e-06	2.09e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PTEN—malignant glioma	2.09e-06	2.09e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.07e-06	2.08e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.07e-06	2.08e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	2.07e-06	2.07e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—malignant glioma	2.05e-06	2.06e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—malignant glioma	2.04e-06	2.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—malignant glioma	2.04e-06	2.04e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—malignant glioma	2.04e-06	2.04e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—KRAS—malignant glioma	2.03e-06	2.03e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—KRAS—malignant glioma	2e-06	2e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—KRAS—malignant glioma	1.99e-06	1.99e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—KRAS—malignant glioma	1.96e-06	1.96e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTEN—malignant glioma	1.96e-06	1.96e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	1.95e-06	1.96e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—malignant glioma	1.95e-06	1.95e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—STAT3—malignant glioma	1.93e-06	1.93e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—malignant glioma	1.92e-06	1.93e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—malignant glioma	1.89e-06	1.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—malignant glioma	1.89e-06	1.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—STAT3—malignant glioma	1.87e-06	1.87e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—STAT3—malignant glioma	1.87e-06	1.87e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	1.86e-06	1.87e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—malignant glioma	1.86e-06	1.86e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—malignant glioma	1.86e-06	1.86e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.83e-06	1.84e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.83e-06	1.83e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PIK3CA—malignant glioma	1.82e-06	1.82e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.81e-06	1.81e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—malignant glioma	1.8e-06	1.81e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	1.8e-06	1.8e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1.8e-06	1.8e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MYC—malignant glioma	1.79e-06	1.8e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—malignant glioma	1.79e-06	1.79e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—malignant glioma	1.78e-06	1.78e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.77e-06	1.78e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—malignant glioma	1.77e-06	1.77e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3CA—malignant glioma	1.76e-06	1.76e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3CA—malignant glioma	1.76e-06	1.76e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EGFR—malignant glioma	1.75e-06	1.76e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—malignant glioma	1.74e-06	1.74e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—malignant glioma	1.74e-06	1.74e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MYC—malignant glioma	1.73e-06	1.74e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MYC—malignant glioma	1.73e-06	1.74e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—malignant glioma	1.73e-06	1.74e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.73e-06	1.73e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—malignant glioma	1.72e-06	1.72e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—malignant glioma	1.72e-06	1.72e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EGFR—malignant glioma	1.7e-06	1.7e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EGFR—malignant glioma	1.7e-06	1.7e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—KRAS—malignant glioma	1.66e-06	1.66e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KRAS—malignant glioma	1.6e-06	1.61e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KRAS—malignant glioma	1.6e-06	1.61e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTEN—malignant glioma	1.56e-06	1.56e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.52e-06	1.52e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CA—malignant glioma	1.52e-06	1.52e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.5e-06	1.5e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—malignant glioma	1.5e-06	1.5e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—malignant glioma	1.49e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—malignant glioma	1.47e-06	1.47e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CA—malignant glioma	1.47e-06	1.47e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CA—malignant glioma	1.47e-06	1.47e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.47e-06	1.47e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	1.47e-06	1.47e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—malignant glioma	1.44e-06	1.44e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—malignant glioma	1.44e-06	1.44e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—malignant glioma	1.42e-06	1.43e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—malignant glioma	1.42e-06	1.43e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CA—malignant glioma	1.38e-06	1.38e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—malignant glioma	1.24e-06	1.25e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—malignant glioma	1.2e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—malignant glioma	1.2e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—malignant glioma	1.13e-06	1.13e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.1e-06	1.1e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—malignant glioma	9e-07	9.01e-06	CbGpPWpGaD
